Siemens Healthineers
€37.86Change from previous close: +0.66%Absolute change: +€0.25
At a glance
- Revenue growth
- +4.53%
- FY to Sep 2025 vs FY to Sep 2024
- Net income growth
- +10.40%
- FY to Sep 2025 vs FY to Sep 2024
- Net margin
- 9.2%
- FY to Sep 2024: 8.7%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | FY to Sep 2025 | FY to Sep 2024 | FY to Sep 2023 | FY to Sep 2022 | FY to Sep 2021 |
|---|---|---|---|---|---|
| Total revenue | 23,375 | 22,363 | 21,680 | 21,714 | 17,997 |
| Cost of revenue | 14,345 | 13,895 | 13,971 | 13,577 | 11,045 |
| Gross profit | 9,030 | 8,468 | 7,709 | 8,137 | 6,952 |
| Selling, general and administrative | 3,887 | 3,681 | 3,607 | 3,408 | 2,817 |
| Research and development | 1,958 | 1,918 | 1,866 | 1,785 | 1,546 |
| Operating income | 3,164 | 2,809 | 2,133 | 2,924 | 2,568 |
| EBIT | 3,164 | 2,809 | 2,133 | 2,924 | 2,568 |
| EBITDA | 4,074 | 3,736 | 3,229 | 3,941 | 3,307 |
| Interest expense | 425 | 476 | 296 | 118 | 83.0 |
| Pre-tax income | 2,853 | 2,523 | 1,928 | 2,801 | 2,403 |
| Income tax | 686 | 564 | 403 | 746 | 658 |
| Net income | 2,144 | 1,942 | 1,509 | 2,038 | 1,727 |
| Net income to common shareholders | 2,144 | 1,942 | 1,509 | 2,038 | 1,727 |
| Basic EPS | 1.91 | 1.74 | 1.35 | 1.82 | 1.57 |
| Diluted EPS | 1.91 | 1.73 | 1.34 | 1.81 | 1.57 |
| Average shares (basic) | 1,120 | 1,118 | 1,119 | 1,123 | 1,100 |
| Average shares (diluted) | 1,125 | 1,123 | 1,124 | 1,128 | 1,104 |
| Dividend per share | 1.00 | 0.95 | 0.95 | 0.95 | 0.85 |